ID: ALA342892

Max Phase: Preclinical

Molecular Formula: C18H23IO2

Molecular Weight: 398.28

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 16alpha-iodo-17beta-Estradiol
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](I)[C@@H]2O

    Standard InChI:  InChI=1S/C18H23IO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1

    Standard InChI Key:  SSYGGPAGDDGXAF-ZXXIGWHRSA-N

    Associated Targets(non-human)

    Rattus norvegicus 775804 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Estrogen receptor 627 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Estrogen receptor 1901 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Estrogen receptor 420 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 398.28Molecular Weight (Monoisotopic): 398.0743AlogP: 4.02#Rotatable Bonds: 0
    Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
    #RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 10.33CX Basic pKa: CX LogP: 4.46CX LogD: 4.46
    Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.51Np Likeness Score: 2.05

    References

    1. Heiman DF, Senderoff SG, Katzenellenbogen JA, Neeley RJ..  (1980)  Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens.,  23  (9): [PMID:7411555] [10.1021/jm00183a007]
    2. Landvatter SW, Katzenellenbogen JA, McElvany KD, Welch MJ..  (1982)  (2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo.,  25  (11): [PMID:6292424] [10.1021/jm00353a007]
    3. Levesque C, Merand Y, Dufour JM, Labrie C, Labrie F..  (1991)  Synthesis and biological activity of new halo-steroidal antiestrogens.,  34  (5): [PMID:2033587] [10.1021/jm00109a014]
    4. DaSilva JN, van Lier JE..  (1990)  Synthesis and structure-affinity of a series of 7 alpha-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen-receptor-positive cancers.,  33  (1): [PMID:2296033] [10.1021/jm00163a066]

    Source